en

PRODUCT DETAIL

Danengo 150 mg tvrdé kapsuly

Code 6112E
MA number 16/0101/24-S
Product Form: cps dur 100x1x150 mg (blis.OPA/Al/PE+DES/Al/PE)-jednotk.bal.perfor.
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: TAD Pharma GmbH, Germany
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AE DIRECT THROMBIN INHIBITORS
B01AE07 Dabigatran etexilate
Shelf life: 24
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 29.04.2024
Validity: 29.04.2029
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric contraindication: Yes
Pediatric warnings: Yes
PIL: PIL_Danengo 150 mg tvrdé kapsuly_04_2024.pdf  
SPC: SPC_Danengo 150 mg tvrdé kapsuly_04_2024.pdf  
Safety feature Yes
Data update: 02.05.2024
eu-flag.png sk-flag.png